MSDS

_____________________________________________________________________________________________
Eye contact
Specific test data for the substance or mixture is not available.
Skin contact
Specific test data for the substance or mixture is not available.
Ingestion
Specific test data for the substance or mixture is not available.
Component Information
Chemical Name Oral LD50 Dermal LD50 Inhalation LC50
Supplier Trade Secret > 5000 mg/kg ( Rat ) > 2000 mg/kg ( Rabbit ) > 2.2 mg/L ( Rat ) 1 h
Supplier Trade Secret = 500 mg/kg ( Rat ) - -
Information on toxicological effects
Symptoms
No information available.
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Sensitization
No information available.
Mutagenic Effects
No information available.
Carcinogenicity
The table below indicates whether each agency has listed any ingredient as a carcinogen.
This product contains a proprietary material in a non-respirable form. Inhalation of this
substance is unlikely to occur from exposure to this product.
Chemical Name ACGIH IARC NTP OSHA
Supplier Trade Secret Group 3
Supplier Trade Secret A2 Group 1 Known X
ACGIH (American Conference of Governmental Industrial Hygienists)
A2 - Suspected Human Carcinogen
IARC (International Agency for Research on Cancer)
Group 1 - Carcinogenic to Humans
Group 3 - Not Classifiable as to Carcinogenicity in Humans
NTP (National Toxicology Program)
Known - Known Carcinogen
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X - Present
Reproductive toxicity
No information available.
STOT - single exposure
No information available.
STOT - repeated exposure
No information available.
Chronic Toxicity
Contains a known or suspected carcinogen. Avoid repeated exposure. Prolonged exposure
may cause chronic effects.
Target Organ Effects
Respiratory system. Eyes. Skin. Gastrointestinal tract (GI).
Aspiration Hazard
No information available.
Numerical measures of toxicity Product Information
The following values are calculated based on chapter 3.1 of the GHS document
_____________________________________________________________________________________________
1260387 - RollerRock
Revision Date 19-Jul-2015
Page 6 / 9